tiprankstipranks
Garofalo Health Care S.P.A. (DE:GHC)
FRANKFURT:GHC

Garofalo Health Care S.P.A. (GHC) Income Statement

1 Followers

Garofalo Health Care S.P.A. Income Statement

Last quarter (Q ), Garofalo Health Care S.P.A.'s total revenue was €84.30M, an increase of 2.57% from the same quarter last year. In Q, Garofalo Health Care S.P.A.'s net income was €4.64M. See Garofalo Health Care S.P.A.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
€ 314.76M€ 314.76M€ 277.87M€ 206.78M€ 194.36M€ 154.43M
Cost of Revenue
€ 178.93M€ 178.93M€ 157.35M€ 116.76M€ 105.45M€ 84.11M
Gross Profit
€ 135.83M€ 135.83M€ 120.52M€ 90.02M€ 88.91M€ 70.32M
Operating Expense
€ 103.70M€ 103.70M€ 92.16M€ 73.65M€ 66.95M€ 49.88M
Operating Income
€ 32.13M€ 32.13M€ 28.36M€ 16.37M€ 21.96M€ 20.45M
Net Non Operating Interest Income Expense
€ -4.42M€ -4.42M€ -4.46M€ -2.69M€ -2.15M€ -1.17M
Other Income Expense
------
Pretax Income
€ 27.37M€ 27.37M€ 23.99M€ 13.02M€ 18.66M€ 18.03M
Tax Provision
€ 5.94M€ 5.94M€ 5.14M€ 1.24M€ 5.51M€ 3.96M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ 21.43M€ 21.43M€ 18.83M€ 11.78M€ 13.14M€ 13.58M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-€ 829.00K€ 670.00K€ 1.71M€ 1.78M€ 1.37M
Total Expenses
€ 282.64M€ 282.64M€ 249.51M€ 190.41M€ 172.40M€ 133.98M
Net Income From Continuing And Discontinued Operation
€ 21.43M€ 21.43M€ 18.83M€ 11.78M€ 13.14M€ 13.58M
Normalized Income
€ 21.77M€ 21.79M€ 18.94M€ 12.58M€ 14.17M€ 14.72M
Interest Expense
€ 4.20M€ 4.20M€ 4.21M€ 2.54M€ 2.06M€ 1.15M
EBIT
€ 31.57M€ 31.57M€ 28.20M€ 15.56M€ 20.72M€ 19.18M
EBITDA
€ 50.48M€ 49.94M€ 43.72M€ 27.15M€ 31.05M€ 25.39M
Currency in EUR

Garofalo Health Care S.P.A. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis